Log In
BCIQ
Print this Print this
 

BAY 1097761

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionPegylated adrenomedullin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat lung disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today